Amphastar Pharmaceuticals, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Amphastar Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2013 to Q3 2024.
  • Amphastar Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $23.7M, a 6.47% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $23.7M -$1.64M -6.47% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $24.3M +$3.99M +19.7% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $23.4M +$4.83M +26.1% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $25.9M +$5.05M +24.2% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $25.3M +$4.75M +23.1% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $20.3M +$1.59M +8.49% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $18.5M +$2.24M +13.7% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $20.9M +$4.19M +25.1% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $20.5M +$8.94M +77% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $18.7M +$9.24M +97.8% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $16.3M +$9.09M +126% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $16.7M +$11.4M +217% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $11.6M +$3.88M +50.1% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $9.44M -$3.19M -25.3% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $7.21M -$3.98M -35.6% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $5.25M -$5.91M -52.9% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $7.74M -$4.6M -37.3% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $12.6M -$880K -6.51% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $11.2M -$1.1M -8.95% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $11.2M +$1.24M +12.5% Dec 31, 2019 10-K 2021-03-15
Q3 2019 $12.3M +$1.2M +10.8% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $13.5M +$1.76M +15% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $12.3M +$1.58M +14.7% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $9.92M +$1.26M +14.5% Dec 31, 2018 10-K 2020-03-16
Q3 2018 $11.1M +$504K +4.74% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $11.8M +$797K +7.28% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $10.7M +$1.78M +19.9% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $8.66M -$727K -7.74% Dec 31, 2017 10-K 2019-03-15
Q3 2017 $10.6M +$3.08M +40.8% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $11M +$3.07M +39% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $8.94M +$3.53M +65.2% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $9.39M +$4.69M +100% Dec 31, 2016 10-K 2018-03-14
Q3 2016 $7.54M +$3.18M +72.9% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $7.88M +$2.92M +58.9% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $5.41M +$965K +21.7% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $4.7M +$1.11M +30.9% Dec 31, 2015 10-K 2017-03-15
Q3 2015 $4.36M +$1.86M +74.4% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 $4.96M +$1.36M +37.8% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $4.45M Mar 31, 2015 10-Q 2015-05-14
Q4 2014 $3.59M +$711K +24.7% Dec 31, 2014 10-K 2016-03-15
Q3 2014 $2.5M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 $3.6M Jun 30, 2014 10-Q 2014-08-13
Q4 2013 $2.88M Dec 31, 2013 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.